Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2007 Jun 9;334(7605):1175-6.
doi: 10.1136/bmj.39065.460208.80.

Treatment of epilepsy in developing countries

Editorial

Treatment of epilepsy in developing countries

Emilio Perucca. BMJ. .

Abstract

Cheap and effective drugs exist but are not accessible to most patients

PubMed Disclaimer

Conflict of interest statement

Competing interests: EP has received speaker's or consultancy fees or research grants from the manufacturers of carbamazepine and oxcarbazepine (Novartis); gabapentin, phenytoin, and pregabalin (Pfizer); lamotrigine (GlaxoSmithKline); levetiracetam (UCB Pharma); tiagabine, valproate, and vigabatrin (Sanofi Aventis); topiramate (Johnson and Johnson); rufinamide and zonisamide (Eisai).

Comment on

Similar articles

Cited by

References

    1. Kale R. The treatment gap. Epilepsia 2002;43(suppl 6):S31-3. - PubMed
    1. World Health Organization, International Epilepsy Bureau and International League against Epilepsy. Atlas. Epilepsy Care in the World 2005. Geneva: WHO, 2005
    1. Kwan P, Brodie MJ. Phenobarbital for the treatment of epilepsy in the 21st century: a critical review. Epilepsia 2004;45:1141-9. - PubMed
    1. Banu SH, Jahan M, Koli UK, Ferdousi S, Khan NZ, Neville B. Side effects of phenobarbital and carbamazepine in childhood epilepsy: randomised controlled trial. BMJ 2007 doi: 10.1136/bmj.39022.436389.BE - DOI - PMC - PubMed
    1. World Health Organization. Initiative of support to people with epilepsy Geneva: WHO, 1990. (unpublished document WHO/MNH/MND/90.3).

Substances